AST-120 (Kremezin®) for the Renal Protection and Attenuation of Decline in Acute Kidney Disease

Clinical trial NCT07182422 · RECRUITING

Trial details

NCT number: NCT07182422
Sponsor: Chang Gung Memorial Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Kidney Disease Acute Kidney Injury (AKI)

Start date: 2025-09-15
Primary completion: 2027-02-11
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.